Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

Also called NCT03686163

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03686163
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03686163. Randomized; single masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2019-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke
Condition
Acute Ischemic Stroke
Intervention (Drug)
Nerve Growth Factors
Intervention (Drug)
normal saline
Lead sponsor
Jinling Hospital, China (class: other)

Record details

Record id
cardio:ct-nct03686163
Content hash
8e8714642c579c6326acefa2b2859d6a6c94a9b2553cdf500d22cca4e3af8a3b